SCHEDULE 13G/A: Citigroup Entities Disclose 4.5% Passive Stake in Puretech Health Plc
Ownership Disclosure
Citigroup Global Markets Limited and affiliated entities have filed an amended Schedule 13G, reporting a collective beneficial ownership of 4.5% of Puretech Health Plc's Ordinary Shares as of December 31, 2024.
Summary
- Citigroup Global Markets Limited, along with its affiliates Citigroup Global Markets Holdings Bahamas Limited, Citigroup Financial Products Inc., Citigroup Global Markets Holdings Inc., and Citigroup Inc., collectively reported beneficial ownership of 10,703,044 Ordinary Shares of Puretech Health Plc.
- This beneficial ownership represents 4.5% of the total class of Puretech Health Plc's Ordinary Shares.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported passive investment position.
- All reported shares are held with shared voting power and shared dispositive power among the reporting entities.
- The event date requiring this filing was December 31, 2024, and the filing date was February 12, 2025.
Sentiment
Score: 5
Explanation: The document is a neutral, factual disclosure of beneficial ownership by institutional entities. It does not contain positive or negative operational or financial news about the issuer, Puretech Health Plc.
Industry Context
This filing is a routine disclosure of institutional ownership by Citigroup entities in Puretech Health Plc, a common occurrence in the financial industry as large financial institutions manage various investment portfolios. It does not provide specific insights into Puretech Health Plc's operational performance or strategic direction, but rather reflects a passive investment position by a major financial services group.
Stakeholder Impact
- For shareholders, this filing confirms the continued passive investment by Citigroup entities, providing transparency regarding significant institutional holdings. It does not suggest any immediate operational or strategic impact on Puretech Health Plc.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement |
| 02/12/2025 | Date of filing and signing of the Schedule 13G |
Keywords
Puretech Health Plc, Citigroup, Schedule 13G, Beneficial Ownership, Ordinary Shares, Institutional Ownership, SEC Filing, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.